Schmidinger M - Search Results

1

Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study.

Motzer RJ, Porta C, Eto M, Powles T, Grünwald V, Hutson TE, Alekseev B, Rha SY, Merchan J, Goh JC, Lalani AA, De Giorgi U, Melichar B, Hong SH, Gurney H, Méndez-Vidal MJ, Kopyltsov E, Tjulandin S, Gordoa TA, Kozlov V, Alyasova A, Winquist E, Maroto P, Kim M, Peer A, Procopio G, Takagi T, Wong S, Bedke J, Schmidinger M, Rodriguez-Lopez K, Burgents J, He C, Okpara CE, McKenzie J, Choueiri TK; CLEAR Trial Investigators. Motzer RJ, et al. Among authors: schmidinger m. J Clin Oncol. 2024 Apr 10;42(11):1222-1228. doi: 10.1200/JCO.23.01569. Epub 2024 Jan 16. J Clin Oncol. 2024. PMID: 38227898 Free article. Clinical Trial.

2

Glutathione in the prevention of cisplatin induced toxicities. A prospectively randomized pilot trial in patients with head and neck cancer and non small cell lung cancer.

Schmidinger M, Budinsky AC, Wenzel C, Piribauer M, Brix R, Kautzky M, Oder W, Locker GJ, Zielinski CC, Steger GG. Schmidinger M, et al. Wien Klin Wochenschr. 2000 Jul 28;112(14):617-23. Wien Klin Wochenschr. 2000. PMID: 11008323 Clinical Trial.

3

Docetaxel monotherapy in heavily pretreated metastatic breast cancer: a multicenter, community-based feasibility trial.

Schmidinger M, Budinsky AC, Wenzel C, Locker GJ, Pluschnig U, Brodowicz T, Kubista E, Maca S, Zabernigg A, Ilsinger P, Seewann L, Hojas S, Blach M, Zielinski CC, Steger GG. Schmidinger M, et al. Cancer Chemother Pharmacol. 2001;47(1):57-62. doi: 10.1007/s002800000204. Cancer Chemother Pharmacol. 2001. PMID: 11221963

4

[Aerobic endurance training for cancer patients].

Crevenna R, Zielinski C, Keilani MY, Schmidinger M, Bittner C, Nuhr M, Nur H, Marosi C, Fialka-Moser V, Quittan M. Crevenna R, et al. Among authors: schmidinger m. Wien Med Wochenschr. 2003;153(9-10):212-6. doi: 10.1046/j.1563-258x.2003.02080.x. Wien Med Wochenschr. 2003. PMID: 12836458 Review. German.

5

Quality of life in patients with non-metastatic differentiated thyroid cancer under thyroxine supplementation therapy.

Crevenna R, Zettinig G, Keilani M, Posch M, Schmidinger M, Pirich C, Nuhr M, Wolzt M, Quittan M, Fialka-Moser V, Dudczak R. Crevenna R, et al. Among authors: schmidinger m. Support Care Cancer. 2003 Sep;11(9):597-603. doi: 10.1007/s00520-003-0474-4. Epub 2003 Jun 3. Support Care Cancer. 2003. PMID: 12783288

6

[Clinical phase II-evaluation of neoadjuvant, cytostatic combination chemotherapy with docetaxel and epidoxorubicin in female breast cancer patients (T1-4, N0-2, M0)].

Wenzel C, Schmidinger M, Locker GJ, Taucher S, Gnant M, Jakesz R, Steger GG. Wenzel C, et al. Among authors: schmidinger m. Wien Klin Wochenschr. 1999 Oct 29;111(20):843-50. Wien Klin Wochenschr. 1999. PMID: 10586489 Clinical Trial. German.

7

Neuromuscular electrical stimulation for a patient with metastatic lung cancer--a case report.

Crevenna R, Marosi C, Schmidinger M, Fialka-Moser V. Crevenna R, et al. Among authors: schmidinger m. Support Care Cancer. 2006 Sep;14(9):970-3. doi: 10.1007/s00520-006-0033-x. Epub 2006 Mar 8. Support Care Cancer. 2006. PMID: 16523264

8

Tumor mutational burden and immune infiltrates in renal cell carcinoma and matched brain metastases.

Steindl A, Alpar D, Heller G, Mair MJ, Gatterbauer B, Dieckmann K, Widhalm G, Hainfellner JA, Schmidinger M, Bock C, Müllauer L, Preusser M, Berghoff AS. Steindl A, et al. Among authors: schmidinger m. ESMO Open. 2021 Apr;6(2):100057. doi: 10.1016/j.esmoop.2021.100057. Epub 2021 Feb 12. ESMO Open. 2021. PMID: 33588158 Free PMC article.

9

Cardiac toxicity of sunitinib and sorafenib in patients with metastatic renal cell carcinoma.

Schmidinger M, Zielinski CC, Vogl UM, Bojic A, Bojic M, Schukro C, Ruhsam M, Hejna M, Schmidinger H. Schmidinger M, et al. Among authors: schmidinger h. J Clin Oncol. 2008 Nov 10;26(32):5204-12. doi: 10.1200/JCO.2007.15.6331. Epub 2008 Oct 6. J Clin Oncol. 2008. PMID: 18838713

10

Dose escalation and pharmacokinetics study of enzastaurin and sunitinib versus placebo and sunitinib in patients with metastatic renal cell carcinoma.

Schmidinger M, Szczylik C, Sternberg CN, Kania M, Kelly CS, Decker R, Hamid O, Faelker T, Escudier B. Schmidinger M, et al. Am J Clin Oncol. 2012 Oct;35(5):493-7. doi: 10.1097/COC.0b013e31821cfc41. Am J Clin Oncol. 2012. PMID: 21654314 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

159 results

Search Page